Cargando…
5-Aminosalicylates to maintain remission in Crohn’s disease: Interpreting conflicting systematic review evidence
5-Aminosalicylates are a class of anti-inflammatory agents that have been used for decades in inflammatory bowel disease. Whilst they are first line for induction and an option for maintenance of remission in ulcerative colitis, the picture in Crohn’s disease is variable. For maintenance of remissio...
Autor principal: | Gordon, Morris |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Baishideng Publishing Group Inc
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5421116/ https://www.ncbi.nlm.nih.gov/pubmed/28533918 http://dx.doi.org/10.4292/wjgpt.v8.i2.99 |
Ejemplares similares
-
Palmitoylation in Crohn’s disease: Current status and future directions
por: Cheng, Wei-Xin, et al.
Publicado: (2021) -
Orphan patients with inflammatory bowel disease - when we treat beyond evidence
por: Privitera, Giuseppe, et al.
Publicado: (2021) -
Antimicrobial peptides and the gut microbiome in inflammatory bowel disease
por: Gubatan, John, et al.
Publicado: (2021) -
Effect of vaccine efficacy on disease transmission with age-structured
por: Yin, Lu, et al.
Publicado: (2022) -
Analogies between medusa and single port surgery in gastroenterology and hepatology: A review
por: Mittermair, Christof, et al.
Publicado: (2021)